Therapeutic Drug Monitoring of Secukinumab in Psoriasis Patients.

Clinical trial NCT04080661 · COMPLETED

Trial details

NCT number: NCT04080661
Sponsor: University Hospital, Ghent
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Psoriasis Vulgaris

Start date: 2018-03-22
Primary completion: 2023-12-31
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.